Sentiss Pharma Private Limited — Ofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Ofloxacin · $6.3M export value · DGFT Verified
Sentiss Pharma Private Limited is the #7 Indian exporter of Ofloxacin with $6.3M in export value and 130 verified shipments. Sentiss Pharma Private Limited holds a 2.1% market share in Ofloxacin exports across 7 countries. The company exports 6 pharmaceutical products worth $28.3M across 4 therapeutic categories.
Sentiss Pharma Private Limited — Ofloxacin Export Profile: Buyers & Destinations
Where Does Sentiss Pharma Private Limited Export Ofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $8.1M | 218 | 81.1% |
| KAZAKISTAN | $806.3K | 21 | 8.0% |
| KAZAKHSTAN | $532.6K | 13 | 5.3% |
| KYRGYZSTAN | $219.7K | 27 | 2.2% |
| KYRGHYSTAN | $194.3K | 33 | 1.9% |
| UZBEKISTAN | $97.3K | 18 | 1.0% |
| UKRAINE | $44.5K | 12 | 0.4% |
| GERMANY | $5.0K | 1 | 0.0% |
| POLAND | $0 | 2 | 0.0% |
Sentiss Pharma Private Limited exports Ofloxacin to 9 countries. The largest destination is RUSSIA accounting for 81.1% of Sentiss Pharma Private Limited's Ofloxacin shipments, followed by KAZAKISTAN (8.0%) and KAZAKHSTAN (5.3%). These destinations reflect Sentiss Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ofloxacin from Sentiss Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LLC SENTISS RUS | RUSSIA | $5.6M | 129 |
| LLC ?SENTISS RUS? | RUSSIA | $2.6M | 77 |
| ALG COMPANY JSC | KAZAKISTAN | $709.1K | 17 |
| ALG COMPANYJSC, | KAZAKISTAN | $212.7K | 6 |
| ALG CO | KAZAKHSTAN | $173.0K | 5 |
| ALG COMPANY JSC, | KAZAKISTAN | $164.0K | 4 |
| NEMAN-PHARM LTD | KYRGHYSTAN | $157.5K | 16 |
| LLC FARMAMIR | KYRGYZSTAN | $81.1K | 14 |
| NEMAN-PHARM LIMITED | KYRGHYSTAN | $49.8K | 5 |
| ALG COMPANYJSC | KAZAKISTAN | $44.2K | 1 |
Sentiss Pharma Private Limited supplies Ofloxacin to 33 buyers globally. The largest buyer is LLC SENTISS RUS (RUSSIA), followed by LLC ?SENTISS RUS? (RUSSIA) and ALG COMPANY JSC (KAZAKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ofloxacin Export Value and How Much Does Sentiss Pharma Private Limited Contribute?
India exported $71.8M worth of Ofloxacin through 15,000 shipments from 1094 suppliers to 180 countries, serving 3,093 buyers globally. Sentiss Pharma Private Limited contributes $6.3M to this total, accounting for 2.1% of India's Ofloxacin exports. Sentiss Pharma Private Limited ships Ofloxacin to 9 countries through 33 buyers.
What Is the Average Shipment Value for Sentiss Pharma Private Limited's Ofloxacin Exports?
Sentiss Pharma Private Limited's average Ofloxacin shipment value is $48.7K per consignment, based on 130 shipments totaling $6.3M. The largest destination is RUSSIA (81.1% of Sentiss Pharma Private Limited's Ofloxacin exports).
How Does Sentiss Pharma Private Limited Compare to Other Indian Ofloxacin Exporters?
Sentiss Pharma Private Limited ranks #7 among 1094 Indian Ofloxacin exporters with a 2.1% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($12.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.1M), MICRO LABS LIMITED ($8.4M). Sentiss Pharma Private Limited processed 130 shipments to 7 destination countries.
What Ofloxacin Formulations Does Sentiss Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DANCIL EYE AND EAR DROPS 0.3%(VIAL DROPPER PLASTIC)5 ML NO1 BAR#8901236012305 SALT#OFLOXACIN B/N:N23401MD:12/23 ED:12/26VLS | $423.3K | 12 |
| CIPROMED EYE DROPS 0.3%,(VIAL-DROPPER PLASTIC)5ML NO.1,BAR#8901236004508,CIPROFLOXACIN HCL, B/N:N23369 MD:11/23 ED:11/25VLS | $293.9K | 12 |
| KOMBINIL ? EYE AND EAR DROPS, (VIAL-DROPPER PLASTIC) 5 ML NO.1,BAR#8901236012107,SALT#DEXAMETHASONE & CIPROFLOXACIN ****VLS | $261.2K | 6 |
| CIPROMED EYE DROPS 0.3%,VIAL DROPPER PLASTIC5ML NO.1,BAR#8901236004508,CIPROFLOXACIN HCL, B/N:N23285 MD:08/23 ED;08/25 | $229.9K | 5 |
| SIGNICEF?EYE DROPS0.5%(VIAL-DROPPER PLASTIC)5 ML NO.1BAR#8901236020065SALT#LEVOFLOXACIN B/N:N24030 MD:01/24 ED:01/27VLS | $221.6K | 6 |
| CIPROMED EYE DROPS 0.3%(VIAL-DROPPER PLASTIC)5ML NO.1,BAR#8901236004508,CIPROFLOXACIN HCL, B/N:N23369 MD:11/23 ED:11/25VLS | $203.8K | 9 |
| DANCIL EYE AND EAR DROPS 0.3%,(VIAL-DROPPER PLASTIC)5ML NO.1,BAR#8901236012305,OFLOXACIN, B/N:N24065 MD:02/24 ED:02/27 | $202.8K | 6 |
| DANCIL EYE AND EAR DROPS 0.3%(VIAL-DROPPER PLASTIC)5 ML NO.1BAR#8901236012305 SALT#OFLOXACINB/N:N24066 MD:02/24 ED:02/27 | $199.9K | 6 |
| KOMBINIL EYE AND EAR DROPS VIAL DROPPERPLASTIC 5ML NO 1 BAR 8901236012107 SALT DEXAMETHASONE CIPROFLOXACIN | $186.7K | 4 |
| CIPROMED EYE DROPS 0.3%(VIAL-DROPPER PLASTIC)5ML NO.1,BAR#8901236004508,CIPROFLOXACIN HCL. B/N:N24059 MD:02/24 ED:02/26 | $151.2K | 6 |
Sentiss Pharma Private Limited exports 219 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DANCIL EYE AND EAR DROPS 0.3%(VIAL DROPPER PLASTIC)5 ML NO1 with 12 shipments worth $423.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Sentiss Pharma Private Limited Compare to Nearest Ofloxacin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MICRO LABS LIMITED | $8.4M | 373 | 33 | $22.5K |
| 6 | AUROBINDO PHARMA LTD | $7.2M | 172 | 12 | $42.0K |
| 7 | SENTISS PHARMA PRIVATE LIMITED ★ | $6.3M | 130 | 7 | $48.7K |
| 9 | MANKIND PHARMA LIMITED | $6.1M | 160 | 3 | $38.4K |
| 10 | FDC LIMITED | $5.5M | 110 | 5 | $50.0K |
Sentiss Pharma Private Limited ranks #7 among 1094 Indian Ofloxacin exporters. Average shipment value of $48.7K compared to the market average of $65.6K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Ofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,841 | 12.3% |
| DELHI AIR CARGO ACC (INDEL4) | 1,504 | 10.0% |
| SAHAR AIR | 1,292 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR | 894 | 6.0% |
| Bombay Air | 655 | 4.4% |
| JNPT/ NHAVA SHEVA SEA | 645 | 4.3% |
| Delhi Air | 361 | 2.4% |
Geopolitical & Trade Policy Impact on Sentiss Pharma Private Limited's Ofloxacin Exports
Recent geopolitical tensions have significantly impacted global shipping routes, affecting Indian pharmaceutical exporters like Sentiss Pharma. The Israel-Iran conflict has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute vessels around the Cape of Good Hope. This diversion has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com)
Additionally, the U.S. has imposed tariffs on pharmaceutical imports, aiming to reduce reliance on foreign generics. While Indian manufacturers supply a significant portion of U.S. generics, tariffs exceeding 10–15% could lead to market exits due to thin profit margins, potentially disrupting supply chains. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive requires stringent quality controls and traceability measures. For companies like Sentiss, adhering to these regulations is crucial to maintain market access and competitiveness.
Sentiss Pharma Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set stringent quality benchmarks. Non-compliance can lead to import bans and reputational damage, as seen in past instances where Indian companies faced restrictions due to quality issues. (comcec.org)
Sentiss Pharma's acquisition of Akorn AG, with its U.S. FDA-approved facility, indicates a commitment to meeting these high standards. This strategic move not only enhances manufacturing capabilities but also ensures adherence to regulatory requirements in key markets. (crisilratings.com)
About Sentiss Pharma Private Limited
Sentiss Pharma Private Limited exports 6 products worth $28.3M. Beyond Ofloxacin, top products include Ciprofloxacin, Levofloxacin, Dexamethasone, Tobramycin, Vati. View the complete Sentiss Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sentiss Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 345 individual customs records matching Sentiss Pharma Private Limited exporting Ofloxacin, covering 219 formulations to 9 countries via 33 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,093+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ofloxacin Export Data from Sentiss Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sentiss Pharma Private Limited's Ofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sentiss Pharma Private Limited
Full Company Profile →
6 products · $28.3M total trade · 4 categories
Ofloxacin Stats
Company Overview
Top Products by Sentiss Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sentiss Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ofloxacin. For current shipment-level data, contact TransData Nexus.